Researchers have uncovered a compound that target mast cells and may inhibit inflammation in patients with inflammatory skin conditions such as rosacea.
Researchers developing a ‘spray on, wash off’ bandage for epidermolysis bullosa
Researchers are working on developing a ‘spray on, wash off’ bandage for patients with epidermolysis bullosa. The details were recently published in a press release (Nov. 18, 2024).
Researchers discover method to restore sweat gland function in burn victims
According to a recent study, researchers have discovered a method of restoring sweat gland function in burn victims.
Upadacitinib efficacious, moderately safe long-term in adolescents with AD
According to a recent study, upadacitinib is efficacious and demonstrated a favorable benefit-risk profile for long-term treatment of atopic dermatitis (AD) in adolescent patients.
Investigators discover how melanoma cells metastasize despite oxidative stress
In a recent study, researchers have discovered a defense mechanism for skin cancer cells that protects them from oxidative stress and helps them metastasize and spread.
AI model effective in screening skin cancer
According to a recent study, an AI model has been found to be effective in screening melanoma and other skin cancers.
Combination dupilumab, abrocitinib effective in treating refractory pediatric AD
According to a recent study, a combination of dupilumab and abrocitinib is effective in treating refractory atopic dermatitis (AD) in pediatric patients.
Cosmetic regimen effectively treats skin redness in rosacea
According to a recent study, a cosmetic regimen of a treatment serum, redness-reducing moisturizer, and sunscreen was effective in reducing redness and improving skin appearance.
Study shows ferulic acid effective as adjuvant treatment for papulopustular rosacea
According to a recent study, topical ferulic acid is effective as an adjuvant treatment for papulopustular rosacea.
New study links stress and psoriasis relapse
According to a recent study, perceived stress can trigger the relapse of psoriatic skin lesions. The study was presented at the European Academy of Dermatology and Venereology Congress in Amsterdam (Sept. 27, 2024).
